Trials / Unknown
UnknownNCT02407210
Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension
A Phase 3, Double-Blind, Randomized, Parallel-Group Study to Evaluate the Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 304 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the efficacy and safety of azilsartan compared to olmesartan medoxomil in patients with grade I or II essential hypertension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | azilsartan | |
| DRUG | Olmesartan medoxomil |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-10-01
- First posted
- 2015-04-02
- Last updated
- 2015-04-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02407210. Inclusion in this directory is not an endorsement.